Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Feb 05, 2021 11:12am
123 Views
Post# 32483731

RE:RE:RE:Nomination

RE:RE:RE:NominationWhat CYDY is doing is working anyway I am going to schedule a call with Leah discussing their marketing and communication strategies. I won't discuss the deal as they did give their rationale justifying it earlier and I don't think she will be adding anything meaningful re the deal.
I just want to see how open they are to approach a more retail friendly approach.
palinc2000 wrote:

Questions from investors are frequently allowed during Investors Day and it seems to me that having a representative of a Fund holding more than 6 million shares and an investor with your background  would  help not only other investors but also the Company....They could make whatever rules they want

 

Wino115 wrote: They've never let anyone other than sell-side analysts ask questions. I don't think that will change anytime soon and seems to be standard now given some of the crazy histrionics past calls on other controversial stocks had. I guess the lawyers have just decided it's better to shut it off for the general public. Only guys like Cytodyn let anyone ask a question, but that's because no sell side would associate with them.
 

 

palinc2000 wrote: I hereby nominate Spceo1 and Wino as representatives pf posters on this MB to ask questions during the Theratech 's CC s 
All those in favor please vote

PS Of course I presume that both nominees are willing to act on our behalf

 




<< Previous
Bullboard Posts
Next >>